MoneyWorks4Me

Medicorp Technologies India Ltd (532108)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532108 NSE: Pharmaceuticals & Drugs | Small Cap | Medicorp Tech Share Price

BSE Share Price
Not Listed

Medicorp Technologies India Ltd (532108)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532108 NSE: Pharmaceuticals & Drugs | Small Cap | Medicorp Tech Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹140 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.2
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
25.92%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
-
Equity
₹19.2 Cr.
Face Value
₹10
All Time Low / High
₹4.00 / 77.10

Medicorp Technologies India stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'96Mar'97Mar'98Mar'99Mar'00Mar'01Mar'02TTM
ROCE % -0%0.2%-2.4%8.2%14.8%1.5%-0.5%-

Growth Parameters

Sales 01.24.919.239.230.638.539
Sales YoY Gr.-2,850%312.7%293.8%104.3%-21.9%25.9%-
Adj EPS -0.1-0.1-1.40.41.9-1.7-2.7-2.5
YoY Gr.-NANANA356.1%-188.8%NA-
BVPS (₹) 9.797.26.412.18.43.44.9
Adj Net
Profit
-0-0.1-1.70.53.6-3.2-5.1-5
Cash Flow from Ops. 0-0.4-0.6-3.12.94.2-4-
Debt/CF from Ops. 0-58-51.9-12.710.413.2-19.4-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA100.8%26.2%25.9%
Adj EPS NANA-286.5%NA
BVPSNA-17.6%-18.7%-58.9%
Share Price - - - -

Key Financial Parameters

Mar'96Mar'97Mar'98Mar'99Mar'00Mar'01Mar'02TTM
Return on
Equity %
-0.5-1.2-15.54.516.8-10.5-18.9-60.5
Op. Profit
Mgn %
23.414.4-7.323.322.56.52.50
Net Profit
Mgn %
-80.5-8.5-34.42.59.2-10.4-13.3-12.5
Debt to
Equity
2.51.93.75.11.12.76.7-
Working Cap
Days
01,0794232342063222930
Cash Conv.
Cycle
024819470761281390

Valuation of Medicorp Tech - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

data not found
No data found!
data
No data found!
data
No data found!
data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Medicorp Technologies India Ltd FAQs

The current trading price of Medicorp Tech on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Medicorp Tech stood at ₹140.3 Cr

The latest P/E ratio of Medicorp Tech as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Medicorp Tech as of 31-Dec-1969 is 14.96.

The 52-week high of Medicorp Tech is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medicorp Tech is ₹38.52 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Medicorp Technologies India Ltd

No data to display
You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now